Home > News > 454 Life Sciences Receives $2.4 million NIH Grant
May 19th, 2004
454 Life Sciences Receives $2.4 million NIH Grant
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation today announced that the Company has received a two-year, $2.4 million grant from the National Human Genome Research Institute, one of the National Institutes of Health. The grant will help fund the scale up of 454 Life Sciences' technology toward sequencing of larger genomes.
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Aspen Aerogels, Inc. to Present at Canaccord Genuity 34th Annual Growth Conference August 11th, 2014